MedPath

Single arm study to see the effect of prapunnadadi lepa in dadru kushta

Phase 2
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2024/07/071233
Lead Sponsor
Dr Amruta Ramesh Rajmane
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients diagnosed as Dadru Kushta as per sign and symptoms which are mention in Ayurvedic Samhita.

2)Gender-Irrespective of gender and socioeconomic status.

3)Age-Above 18 to 60 years.

Exclusion Criteria

1)Pregnant women and lactating women.

2)Less than 18 years and more than 60 years.

3)Mandal with secondary infection & immuno suppressive.

4)Mandal more than 7 in number.

5)Mandal measuring above 10 cm in length and above 10 cm in breadth.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Study the effect of Prapunnadadi Lepa in the management of Dadru Kushta.Timepoint: 10 days
Secondary Outcome Measures
NameTimeMethod
1)To study Dadru Kushta in Ayurvedic perspective. <br/ ><br>2)To study Prapunnadadi Lepa in detail in Dadru Kushta. <br/ ><br>3)To study the efficacy of Prapunnadadi Lepa in Dadru Kushta.Timepoint: 10 days
© Copyright 2025. All Rights Reserved by MedPath